Added to YB: 2024-04-05
Pitch date: 2023-12-31
CSTL [bullish]
Castle Biosciences, Inc.
+82.48%
current return
Author Info
No bio for this author
Company Info
Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus, uveal melanoma, and mental health conditions.
Market Cap
$765.2M
Pitch Price
$21.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.38
P/E
129.87
EV/Sales
1.64
Sector
Health Care Providers and Services
Category
growth
Next Century Growth Investors Micro Cap Strategy New Position: Castle Biosciences, Inc.
CSTL: Medical diagnostics firm w/ skin & esophageal cancer + mental health tests. Prior concerns on M&A abated as skin cancer volumes grow & deals add value. Low penetration across markets signals continued growth. Valuation compressed but balance sheet supports expansion & 2025 cash flow breakeven target.
Read full article (1 min)